Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
05/2009
05/19/2009CA2192268C Amino alcohol derivative and method for preparing the same
05/14/2009WO2009061744A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
05/14/2009WO2009061597A1 Compounds for inhibiting ksp kinesin activity
05/14/2009WO2009031040A3 Compounds with anti-cancer activity
05/14/2009WO2008068540A8 New benzamide derivatives as bradykinin antagonists
05/14/2009US20090124817 Process for Preparing Amorphous Atorvastatin Calcium Nanoparticles
05/14/2009US20090124668 Cyclic derivatives as modulators of chemokine receptor activity
05/14/2009US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them
05/14/2009US20090124559 Soft Protease Inhibitors and Pro-Soft Forms Thereof
05/14/2009US20090123514 Electropolymerizable Monomers and Polymeric Coatings on Implantable Devices Prepared Therefrom
05/14/2009US20090121210 Formation of self-assembled monolayers on silicon substrates
05/14/2009DE102007052900A1 Stereospezifische Hydroxylierung Stereospecific hydroxylation
05/14/2009CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
05/14/2009CA2702995A1 Compounds for inhibiting ksp kinesin activity
05/13/2009EP2058301A1 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof
05/13/2009EP2058300A1 Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation
05/13/2009EP2057117A2 Compounds for treating proliferative disorders
05/13/2009EP1904441A4 Process for producing cyano substituted arene boranes and compounds
05/13/2009EP1856041B1 Crystallisation and purification of glycopyrronium bromide
05/13/2009EP1356812B1 Medicines for treatment and prevention of neurogenic pain
05/13/2009EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
05/13/2009CN101432275A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/13/2009CN101432263A Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/13/2009CN101432262A Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/13/2009CN101432261A N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
05/13/2009CN101431996A Inhibitors of protein prenyltransferases
05/13/2009CN101429153A Synthesis of N- alkyl substituted maleimide
05/13/2009CN101429152A Method for extracting bilirubin from oxgall
05/13/2009CN101429151A IDO restrainer containing (E)-4-(beta-bromo vinyl)benzoyloxy structure
05/13/2009CN101429150A Method for synthesis of 3,4-diaryl pyrrole derivant with photocatalysis
05/13/2009CN101429135A Brnsted acid compound containing amide group, preparation and uses thereof
05/13/2009CN100486965C 3-acyl-pyrrolidine-2,4-diketo compound and herbicidal activity
05/13/2009CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use
05/12/2009US7531673 Preparation of amino acid amides
05/12/2009US7531655 Large conductance calcium-activated K channel opener
05/12/2009US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
05/12/2009US7531526 Boronic ester and acid compounds, synthesis and uses
05/12/2009CA2471422C Process for forming polyalkenyl acylating agents
05/12/2009CA2389156C Benzamidine derivatives
05/07/2009WO2009057784A1 Heterocyclic compound
05/07/2009WO2009057769A1 Novel sulfonic acid salt and derivative thereof, photoacid generator agent, and resist material and pattern formation method using the photoacid generator agent
05/07/2009WO2009057567A1 Luminescent-element material and luminescent element
05/07/2009WO2009035553A3 Analogs of tetramic acid
05/07/2009WO2009023160A3 Novel inhibitors of bacterial sortase enzymes and methods of using the same
05/07/2009WO2007117665A3 Derivatization-enhanced analysis of amino acids and peptides
05/07/2009US20090118520 Avoiding selective hydrolysis of methyl ester in the presence of tert-butyl ester by using a mineral aid simultaneously to induce acid-catalyzed cleavageof ketal and the hydroxy protecting group; avoid the use of air- and moisture-sensitive reagents; cost efficiency; simplification
05/07/2009US20090118353 Medicinal composition
05/07/2009US20090118335 Acid Secretion Inhibitor
05/07/2009US20090118330 Diurea derivatives
05/07/2009US20090118291 Histone deacetylase inhibitors
05/07/2009US20090118289 (Biphenyl) Carboxylic Acids and Derivatives Thereof
05/07/2009US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
05/07/2009US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses
05/07/2009US20090118169 Novel compounds and pharmaceutical use thereof
05/07/2009US20090118160 Heterocyclic compounds and methods of use
05/07/2009US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors
05/06/2009EP1729774A4 Pyrrolidine compounds
05/06/2009EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
05/06/2009EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/06/2009CN101426497A Small molecule apoptosis promoters
05/06/2009CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases
05/06/2009CN101423488A Method for preparing dihydro pyrrole derivates
05/06/2009CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient
05/06/2009CN100486030C Electrolytic solution and battery
05/06/2009CN100484920C Process for preparing high purity atorvastatin calcium
05/05/2009US7528287 Polymerizing tetrahydrofuran in the presence of a catalyst, an accelerator, and an ionic liquid composed of 5-methyl-2-pyrrlidon-1-ylalkylammonium organosulfonate or organosulfonimide at 0-75 degrees C. and separating the polymer from the ionic liquid that contains the catalyst
05/05/2009US7528264 Hydride reduction process for preparing quinolone intermediates
05/05/2009US7528261 Small molecule compound having indolocarbazole moiety and divalent linkage
05/05/2009US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors
05/05/2009US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis
05/05/2009US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells
05/05/2009US7528136 Prolinamide derivatives as NK3 antagonists
05/05/2009US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction
05/05/2009US7527912 chemically amplified resists; generates a sulfonic acid upon exposure to high energy radiation; ArF immersion microlithography; line edge roughness; sulfonium or iodonium salts, oximes and imides of1,1,3,3,3-pentafluoro-2-acyloxypropane-1-sulfonates having a carbonyl or carboxyl group
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
04/2009
04/30/2009WO2009055289A2 Therapeutic substituted lactams
04/30/2009WO2009054793A1 Thiophene 1,2,4-triazole derivatives as modulators of mglur5
04/30/2009WO2009054693A2 Process for the preparation of atorvastatin
04/30/2009WO2009054682A2 Prodrug of atrovastatin by cholesterol's synthesis inhibitors
04/30/2009WO2009054531A1 Liquid crystal aligning agent, method for forming liquid crystal alignment film, and liquid crystal display device
04/30/2009WO2009054150A1 Tetrapyrrole derivative, and use thereof for medical purposes
04/30/2009WO2009053763A1 New non-peptide derivatives as bradykinin b1 antagonists
04/30/2009WO2009053446A2 Pregabalin intermediates and process for preparing them and pregabalin
04/30/2009WO2009053441A1 Phenylpyrrolidine compounds
04/30/2009WO2008126106A8 Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts
04/30/2009US20090111992 Alkyl ether derivatives or salts thereof
04/30/2009US20090111808 Novel histamine h3-receptor ligands and their therapeutic applications
04/30/2009US20090111791 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same
04/30/2009US20090111776 Novel tetracycline derivatives as antibacterial agents
04/30/2009US20090111731 Novel topical application agents against mimic and age-related wrinkles
04/30/2009US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex
04/30/2009CA2703479A1 Therapeutic substituted lactams
04/30/2009CA2703458A1 Phenylpyrrolidine compounds
04/30/2009CA2703290A1 New non-peptide derivatives as bradykinin b1 antagonists
04/29/2009EP2053040A1 Pregabalin intermediates and process for preparing them and Pregabalin
04/29/2009EP2051707A2 Inhibitors of plasma kallikrein
04/29/2009EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia
04/29/2009EP1438288B1 Substituted thioacetamides
04/29/2009CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
04/29/2009CN101421218A Cycloalkyl-phenylsubstituierte cyclische ketoenole
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 404